United Press International - Health Business - GTx begins trial of prostate-cancer drugGTx begins trial of prostate-cancer drug MEMPHIS, April 21 (UPI) — GTx said Friday it is initiating a phase 3b trial of Acapodene in men undergoing androgen deprivation therapy for prostate cancer. Prostate-cancer patients who have completed the full two-year treatment course in the pivotal [...]
Read The Full Article:
http://www.drilltools.org/299
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!
Powered by blogdig.net